Control of human lymphocyte proliferation by soluble factors.
D001402:B-Lymphocytes / Q000276:immunology; D002460:Cell Line; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D005334:Fever / Q000209:etiology; D006133:Growth Substances / Q000378:metabolism / Q000502:physiology; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000209:etiology; D007375:Interleukin-1 / Q000096:biosynthesis / Q000302:isolation & purification / Q000502:physiology; D007376:Interleukin-2 / Q000096:biosynthesis / Q000302:isolation & purification / Q000502:physiology; D015847:Interleukin-4; D008213:Lymphocyte Activation; D008211:Lymphocyte Cooperation; D008222:Lymphokines / Q000378:metabolism / Q000502:physiology*; D008223:Lymphoma / Q000276:immunology; D009000:Monocytes / Q000276:immunology; D015846:Monokines; D011506:Proteins / Q000502:physiology*; D011971:Receptors, Immunologic; D015375:Receptors, Interleukin-2; D013601:T-Lymphocytes / Q000276:immunology
D006133:Growth Substances; D007375:Interleukin-1; D007376:Interleukin-2; D008222:Lymphokines; D015846:Monokines; D011506:Proteins; D011971:Receptors, Immunologic; D015375:Receptors, Interleukin-2; D015847:Interleukin-4